Improving procedural and one-year outcome after contact force-guided pulmonary vein isolation: the role of interlesion distance, ablation index, and contact force variability in the ‘CLOSE’-protocol

We have recently shown that a contact force (CF)-guided ablation protocol respecting region-specific criteria of lesion contiguity and lesion depth ('CLOSE' protocol) is associated with high incidence of acute durable pulmonary vein (PV) isolation (PVI) and a high single-procedure arrhythm...

Full description

Saved in:
Bibliographic Details
Published inEuropace (London, England) Vol. 20; no. FI_3; pp. f419 - f427
Main Authors Phlips, Thomas, Taghji, Philippe, El Haddad, Milad, Wolf, Michael, Knecht, Sébastien, Vandekerckhove, Yves, Tavernier, René, Duytschaever, Mattias
Format Journal Article
LanguageEnglish
Published England 01.11.2018
Online AccessGet full text
ISSN1099-5129
1532-2092
1532-2092
DOI10.1093/europace/eux376

Cover

Abstract We have recently shown that a contact force (CF)-guided ablation protocol respecting region-specific criteria of lesion contiguity and lesion depth ('CLOSE' protocol) is associated with high incidence of acute durable pulmonary vein (PV) isolation (PVI) and a high single-procedure arrhythmia-free survival at 1 year. In the present study, we compared efficiency, safety, and efficacy of 'CLOSE'-guided PVI to conventional CF-guided PVI (CONV-CF). Fifty consecutive paroxysmal atrial fibrillation (AF) patients underwent PV encircling using a CF-sensing catheter targeting an interlesion distance (ILD) ≤6 mm and ablation index (AI) ≥400 and ≥550 at posterior and anterior wall ('CLOSE' group). Results were compared to the last 50 patients undergoing 'CONV-CF'. All patients underwent adenosine testing after PVI. Arrhythmia recurrence was defined as any atrial tachyarrhythmia (ATA) >30 s on Holter at 3, 6, and 12 months. Clinical characteristics did not differ. Contact force variability was comparable in between both groups (proportion of applications with intermittent contact 2% in 'CLOSE' vs. 1% in CONV-CF, P = 0.67). In the 'CLOSE' group, procedure time and radiofrequency (RF) time per circle were shorter (respectively 149 ± 33 min vs. 192 ± 42 min, P < 0.0001 and 18 ± 4 min vs 28 ± 7.5 min, P < 0.0001) and incidence of adenosine-proof isolation was higher (97% vs. 82%, P < 0.001). No complications were observed in the 'CLOSE' group, one tamponade in the 'CONV-CF' group. At 12 months, single-procedure freedom from ATA was 94% in 'CLOSE' vs. 80% in 'CONV-CF' group (P < 0.05). In both groups, the majority of reconnections at repeat were associated with either ILD > 6 mm and/or AI < 400/550 (100% vs. 83%, P = 0.99). 'CLOSE'-guided PVI improves procedural and 1 year outcome in CF-guided PVI while shortening procedure time. Improvement cannot be explained by differences in CF variability and is most likely due to the strict application of criteria for contiguity and ablation index. A randomized controlled trial is needed to exclude the possible contribution of a learning curve.
AbstractList We have recently shown that a contact force (CF)-guided ablation protocol respecting region-specific criteria of lesion contiguity and lesion depth ('CLOSE' protocol) is associated with high incidence of acute durable pulmonary vein (PV) isolation (PVI) and a high single-procedure arrhythmia-free survival at 1 year. In the present study, we compared efficiency, safety, and efficacy of 'CLOSE'-guided PVI to conventional CF-guided PVI (CONV-CF). Fifty consecutive paroxysmal atrial fibrillation (AF) patients underwent PV encircling using a CF-sensing catheter targeting an interlesion distance (ILD) ≤6 mm and ablation index (AI) ≥400 and ≥550 at posterior and anterior wall ('CLOSE' group). Results were compared to the last 50 patients undergoing 'CONV-CF'. All patients underwent adenosine testing after PVI. Arrhythmia recurrence was defined as any atrial tachyarrhythmia (ATA) >30 s on Holter at 3, 6, and 12 months. Clinical characteristics did not differ. Contact force variability was comparable in between both groups (proportion of applications with intermittent contact 2% in 'CLOSE' vs. 1% in CONV-CF, P = 0.67). In the 'CLOSE' group, procedure time and radiofrequency (RF) time per circle were shorter (respectively 149 ± 33 min vs. 192 ± 42 min, P < 0.0001 and 18 ± 4 min vs 28 ± 7.5 min, P < 0.0001) and incidence of adenosine-proof isolation was higher (97% vs. 82%, P < 0.001). No complications were observed in the 'CLOSE' group, one tamponade in the 'CONV-CF' group. At 12 months, single-procedure freedom from ATA was 94% in 'CLOSE' vs. 80% in 'CONV-CF' group (P < 0.05). In both groups, the majority of reconnections at repeat were associated with either ILD > 6 mm and/or AI < 400/550 (100% vs. 83%, P = 0.99). 'CLOSE'-guided PVI improves procedural and 1 year outcome in CF-guided PVI while shortening procedure time. Improvement cannot be explained by differences in CF variability and is most likely due to the strict application of criteria for contiguity and ablation index. A randomized controlled trial is needed to exclude the possible contribution of a learning curve.
We have recently shown that a contact force (CF)-guided ablation protocol respecting region-specific criteria of lesion contiguity and lesion depth ('CLOSE' protocol) is associated with high incidence of acute durable pulmonary vein (PV) isolation (PVI) and a high single-procedure arrhythmia-free survival at 1 year. In the present study, we compared efficiency, safety, and efficacy of 'CLOSE'-guided PVI to conventional CF-guided PVI (CONV-CF).AimsWe have recently shown that a contact force (CF)-guided ablation protocol respecting region-specific criteria of lesion contiguity and lesion depth ('CLOSE' protocol) is associated with high incidence of acute durable pulmonary vein (PV) isolation (PVI) and a high single-procedure arrhythmia-free survival at 1 year. In the present study, we compared efficiency, safety, and efficacy of 'CLOSE'-guided PVI to conventional CF-guided PVI (CONV-CF).Fifty consecutive paroxysmal atrial fibrillation (AF) patients underwent PV encircling using a CF-sensing catheter targeting an interlesion distance (ILD) ≤6 mm and ablation index (AI) ≥400 and ≥550 at posterior and anterior wall ('CLOSE' group). Results were compared to the last 50 patients undergoing 'CONV-CF'. All patients underwent adenosine testing after PVI. Arrhythmia recurrence was defined as any atrial tachyarrhythmia (ATA) >30 s on Holter at 3, 6, and 12 months. Clinical characteristics did not differ. Contact force variability was comparable in between both groups (proportion of applications with intermittent contact 2% in 'CLOSE' vs. 1% in CONV-CF, P = 0.67). In the 'CLOSE' group, procedure time and radiofrequency (RF) time per circle were shorter (respectively 149 ± 33 min vs. 192 ± 42 min, P < 0.0001 and 18 ± 4 min vs 28 ± 7.5 min, P < 0.0001) and incidence of adenosine-proof isolation was higher (97% vs. 82%, P < 0.001). No complications were observed in the 'CLOSE' group, one tamponade in the 'CONV-CF' group. At 12 months, single-procedure freedom from ATA was 94% in 'CLOSE' vs. 80% in 'CONV-CF' group (P < 0.05). In both groups, the majority of reconnections at repeat were associated with either ILD > 6 mm and/or AI < 400/550 (100% vs. 83%, P = 0.99).Methods and resultsFifty consecutive paroxysmal atrial fibrillation (AF) patients underwent PV encircling using a CF-sensing catheter targeting an interlesion distance (ILD) ≤6 mm and ablation index (AI) ≥400 and ≥550 at posterior and anterior wall ('CLOSE' group). Results were compared to the last 50 patients undergoing 'CONV-CF'. All patients underwent adenosine testing after PVI. Arrhythmia recurrence was defined as any atrial tachyarrhythmia (ATA) >30 s on Holter at 3, 6, and 12 months. Clinical characteristics did not differ. Contact force variability was comparable in between both groups (proportion of applications with intermittent contact 2% in 'CLOSE' vs. 1% in CONV-CF, P = 0.67). In the 'CLOSE' group, procedure time and radiofrequency (RF) time per circle were shorter (respectively 149 ± 33 min vs. 192 ± 42 min, P < 0.0001 and 18 ± 4 min vs 28 ± 7.5 min, P < 0.0001) and incidence of adenosine-proof isolation was higher (97% vs. 82%, P < 0.001). No complications were observed in the 'CLOSE' group, one tamponade in the 'CONV-CF' group. At 12 months, single-procedure freedom from ATA was 94% in 'CLOSE' vs. 80% in 'CONV-CF' group (P < 0.05). In both groups, the majority of reconnections at repeat were associated with either ILD > 6 mm and/or AI < 400/550 (100% vs. 83%, P = 0.99).'CLOSE'-guided PVI improves procedural and 1 year outcome in CF-guided PVI while shortening procedure time. Improvement cannot be explained by differences in CF variability and is most likely due to the strict application of criteria for contiguity and ablation index. A randomized controlled trial is needed to exclude the possible contribution of a learning curve.Conclusion'CLOSE'-guided PVI improves procedural and 1 year outcome in CF-guided PVI while shortening procedure time. Improvement cannot be explained by differences in CF variability and is most likely due to the strict application of criteria for contiguity and ablation index. A randomized controlled trial is needed to exclude the possible contribution of a learning curve.
Author Vandekerckhove, Yves
El Haddad, Milad
Wolf, Michael
Phlips, Thomas
Tavernier, René
Knecht, Sébastien
Duytschaever, Mattias
Taghji, Philippe
Author_xml – sequence: 1
  givenname: Thomas
  surname: Phlips
  fullname: Phlips, Thomas
  organization: Department of Cardiology, Sint-Jan Hospital Bruges, Ruddershove 10, Bruges, Belgium
– sequence: 2
  givenname: Philippe
  surname: Taghji
  fullname: Taghji, Philippe
  organization: Department of Cardiology, Sint-Jan Hospital Bruges, Ruddershove 10, Bruges, Belgium
– sequence: 3
  givenname: Milad
  surname: El Haddad
  fullname: El Haddad, Milad
  organization: Department of Internal Medicine, Ghent University, De Pintelaan 185, Ghent, Belgium
– sequence: 4
  givenname: Michael
  surname: Wolf
  fullname: Wolf, Michael
  organization: Department of Cardiology, Sint-Jan Hospital Bruges, Ruddershove 10, Bruges, Belgium
– sequence: 5
  givenname: Sébastien
  surname: Knecht
  fullname: Knecht, Sébastien
  organization: Department of Cardiology, Sint-Jan Hospital Bruges, Ruddershove 10, Bruges, Belgium
– sequence: 6
  givenname: Yves
  surname: Vandekerckhove
  fullname: Vandekerckhove, Yves
  organization: Department of Cardiology, Sint-Jan Hospital Bruges, Ruddershove 10, Bruges, Belgium
– sequence: 7
  givenname: René
  surname: Tavernier
  fullname: Tavernier, René
  organization: Department of Cardiology, Sint-Jan Hospital Bruges, Ruddershove 10, Bruges, Belgium
– sequence: 8
  givenname: Mattias
  surname: Duytschaever
  fullname: Duytschaever, Mattias
  organization: Department of Cardiology, Sint-Jan Hospital Bruges, Ruddershove 10, Bruges, Belgium, Department of Internal Medicine, Ghent University, De Pintelaan 185, Ghent, Belgium
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29315411$$D View this record in MEDLINE/PubMed
BookMark eNqFUctuFDEQtFBQ3mduyEcOGeLHeDbmhlYhRFopB8h55PG0g5HHHmzPJnvLZ8Av8Rn5kpidBAkOcOq2urqq2nWAdnzwgNArSt5SIvkpTDGMSkNp7viieYH2qeCsYkSyndITKStBmdxDByl9JYQsmBS7aI9JTkVN6T76eTmMMaytv8GlauinqBxWvsdFqNqAijhMWYcBsDIZItbBZ6UzNiFqqG4m20OPx8kNwau4wWuwHtsUnMo2-Hc4fwEcgwMcDLa-EDhIZYB7m7LyGk6w6mZsGfdwd7LV_kMEr1W0qrPO5k0BbSkf7r8vV1efzh_uf1TFdw46uCP00iiX4PipHqLrD-eflx-r1dXF5fL9qtI1qXMlNKmJVKavGyBEi9pwzRadrjkx5c0Jr89MZ5hhmhoAIgTv6YJ0vOloIxvCDxGZeSc_qs2tcq4dox3K9S0l7a9Y2udY2jmWsvJmXilev02QcjvYpME55SFMqaXyTApRMykL9PUTdOoG6H9TP0dWAGIG6BhSimBabfP2B3NU1v3Dw-lfe_9z_QhUesbZ
CitedBy_id crossref_primary_10_1111_jce_15433
crossref_primary_10_1111_jce_15674
crossref_primary_10_1002_joa3_13035
crossref_primary_10_1007_s10840_022_01229_6
crossref_primary_10_1007_s10840_024_01810_1
crossref_primary_10_3389_fcvm_2022_1073239
crossref_primary_10_1007_s10840_019_00691_z
crossref_primary_10_35336_VA_1327
crossref_primary_10_1111_prd_12561
crossref_primary_10_1007_s10840_020_00751_9
crossref_primary_10_1093_europace_euad259
crossref_primary_10_1093_europace_euae103
crossref_primary_10_1002_joa3_12868
crossref_primary_10_1016_j_hlc_2021_02_017
crossref_primary_10_1136_openhrt_2024_002873
crossref_primary_10_1148_radiol_212644
crossref_primary_10_3390_ijerph20075250
crossref_primary_10_1111_jce_13928
crossref_primary_10_1007_s10554_022_02533_y
crossref_primary_10_2169_internalmedicine_9367_22
crossref_primary_10_1016_j_pcad_2021_06_005
crossref_primary_10_1016_j_rccl_2019_01_001
crossref_primary_10_1001_jamacardio_2023_0212
crossref_primary_10_1016_j_jacep_2023_05_015
crossref_primary_10_3389_fcvm_2024_1449623
crossref_primary_10_1155_2021_8821467
crossref_primary_10_1007_s10840_019_00687_9
crossref_primary_10_1111_jce_16194
crossref_primary_10_1007_s00392_021_01973_1
crossref_primary_10_1002_joa3_12611
crossref_primary_10_1111_pace_14578
crossref_primary_10_1111_jce_14124
crossref_primary_10_1111_jce_15575
crossref_primary_10_1111_pace_14228
crossref_primary_10_1016_j_hrthm_2019_01_030
crossref_primary_10_1111_jce_16542
crossref_primary_10_3390_jcm12154982
crossref_primary_10_35336_VA_2021_E_3_16
crossref_primary_10_1007_s10840_018_0501_5
crossref_primary_10_1016_j_ijcha_2020_100574
crossref_primary_10_3389_fcvm_2023_1141698
crossref_primary_10_1136_openhrt_2021_001718
crossref_primary_10_3389_fcvm_2022_937913
crossref_primary_10_1007_s11936_024_01043_5
crossref_primary_10_3904_kjm_2022_97_1_5
crossref_primary_10_35336_VA_1310
crossref_primary_10_1111_jce_14598
crossref_primary_10_3390_biomedicines11123261
crossref_primary_10_1016_j_recesp_2020_10_022
crossref_primary_10_1253_circj_CJ_24_0476
crossref_primary_10_47803_rjc_2020_30_4_553
crossref_primary_10_1016_j_ejim_2023_02_011
crossref_primary_10_1093_europace_euad244
crossref_primary_10_1016_j_jacep_2019_12_006
crossref_primary_10_1016_j_banm_2024_04_004
crossref_primary_10_1016_j_jacep_2018_11_020
crossref_primary_10_1093_europace_euaa418
crossref_primary_10_3389_fcvm_2023_1223064
crossref_primary_10_1016_j_ijcard_2022_10_013
crossref_primary_10_1111_jce_15356
crossref_primary_10_1016_j_jacep_2022_06_007
crossref_primary_10_1111_jce_13730
crossref_primary_10_36660_abc_20240355i
crossref_primary_10_1007_s10840_024_01771_5
crossref_primary_10_3389_fcvm_2022_949918
crossref_primary_10_1002_joa3_13192
crossref_primary_10_1111_jce_14706
crossref_primary_10_1111_jce_16208
crossref_primary_10_1136_bmjopen_2018_023775
crossref_primary_10_1093_europace_euab279
crossref_primary_10_3390_jcm10184268
crossref_primary_10_1002_joa3_12544
crossref_primary_10_1007_s10840_023_01690_x
crossref_primary_10_1111_jce_14381
crossref_primary_10_1111_pace_13673
crossref_primary_10_3389_fcvm_2021_782451
crossref_primary_10_1002_joa3_12424
crossref_primary_10_1111_pace_14656
crossref_primary_10_1016_j_jacep_2023_08_005
crossref_primary_10_1016_j_jacep_2020_08_023
crossref_primary_10_3389_fcvm_2023_1073108
crossref_primary_10_1111_jce_14495
crossref_primary_10_1159_000508888
crossref_primary_10_3389_fcvm_2025_1552340
crossref_primary_10_35336_VA_2020_1_55_62
crossref_primary_10_1093_europace_euad221
crossref_primary_10_1111_jce_15106
crossref_primary_10_1016_j_repc_2021_05_019
crossref_primary_10_3390_diseases12020038
crossref_primary_10_1007_s10840_020_00881_0
crossref_primary_10_1007_s10840_025_01982_4
crossref_primary_10_1007_s10840_022_01434_3
crossref_primary_10_35336_VA_1186
crossref_primary_10_1016_j_hrthm_2024_03_017
crossref_primary_10_1111_pace_14309
crossref_primary_10_3389_fcvm_2021_817299
crossref_primary_10_1007_s10840_020_00927_3
crossref_primary_10_1093_europace_euad310
crossref_primary_10_5604_01_3001_0014_1503
crossref_primary_10_1093_europace_euae088
crossref_primary_10_1093_europace_euac103
crossref_primary_10_1007_s10840_019_00565_4
crossref_primary_10_1111_jce_15809
crossref_primary_10_1007_s00399_022_00843_1
crossref_primary_10_1007_s00399_022_00889_1
crossref_primary_10_1007_s10840_023_01709_3
crossref_primary_10_1111_jce_14156
crossref_primary_10_1111_pace_14315
crossref_primary_10_1253_circj_CJ_19_0993
crossref_primary_10_1016_j_jacep_2023_05_034
crossref_primary_10_1111_jce_15000
crossref_primary_10_1111_jce_16573
crossref_primary_10_2459_JCM_0000000000000779
crossref_primary_10_1016_j_jacep_2020_09_027
crossref_primary_10_1111_jce_13625
crossref_primary_10_1002_joa3_13082
crossref_primary_10_1093_europace_euab261
crossref_primary_10_1093_europace_euab268
crossref_primary_10_1093_europace_euac236
crossref_primary_10_31083_j_rcm2504140
crossref_primary_10_1111_jce_14709
crossref_primary_10_1016_j_jacep_2024_02_026
crossref_primary_10_1161_CIRCEP_120_009112
crossref_primary_10_1111_pace_14555
crossref_primary_10_1186_s42444_020_00021_9
crossref_primary_10_1007_s10840_023_01663_0
crossref_primary_10_1111_jce_16006
crossref_primary_10_3389_fcvm_2022_922910
crossref_primary_10_1111_jce_14980
crossref_primary_10_33590_emjcardiol_10310415
crossref_primary_10_3389_fcvm_2022_941434
crossref_primary_10_36660_abc_20240355
crossref_primary_10_1111_jce_15717
crossref_primary_10_1093_europace_euaa383
crossref_primary_10_1111_jvim_17251
crossref_primary_10_1093_europace_euae067
crossref_primary_10_1253_circj_CJ_18_0361
crossref_primary_10_1093_europace_euab114
crossref_primary_10_1093_europace_euaa147
crossref_primary_10_1093_europace_euab115
crossref_primary_10_36660_abc_20230544
crossref_primary_10_1111_jce_15152
crossref_primary_10_1016_j_jacep_2019_09_004
crossref_primary_10_1016_j_jacep_2024_09_021
crossref_primary_10_1016_j_ahj_2022_02_009
crossref_primary_10_1111_jce_15028
crossref_primary_10_1093_europace_euae072
crossref_primary_10_1007_s00392_019_01428_8
crossref_primary_10_1016_j_jacep_2022_10_039
crossref_primary_10_1093_europace_euz226
crossref_primary_10_1016_j_jacep_2020_06_030
crossref_primary_10_1093_europace_euae194
crossref_primary_10_2217_cer_2019_0165
crossref_primary_10_1111_jce_15703
crossref_primary_10_1007_s10840_022_01131_1
crossref_primary_10_1038_s41598_020_61322_6
crossref_primary_10_36660_abc_20200204
crossref_primary_10_1007_s10840_021_01053_4
crossref_primary_10_1007_s00399_021_00794_z
crossref_primary_10_1093_ehjopen_oeae014
crossref_primary_10_1002_joa3_12696
crossref_primary_10_1007_s00380_021_01971_3
crossref_primary_10_1111_jce_16230
crossref_primary_10_1016_j_ipej_2021_08_005
crossref_primary_10_1111_jce_16026
crossref_primary_10_1111_jce_15610
crossref_primary_10_1111_jce_15731
crossref_primary_10_1007_s10840_021_00990_4
crossref_primary_10_1093_europace_euae043
crossref_primary_10_1111_jce_15855
crossref_primary_10_3390_jcdd10030098
crossref_primary_10_1093_europace_euz115
crossref_primary_10_3389_fcvm_2022_986207
crossref_primary_10_1016_j_hlc_2021_04_007
crossref_primary_10_1016_j_hrcr_2021_09_012
crossref_primary_10_1016_j_hroo_2024_11_025
crossref_primary_10_1111_jce_15294
crossref_primary_10_35336_VA_2020_3_9_24
crossref_primary_10_1093_eurheartj_ehaa612
crossref_primary_10_1161_CIRCOUTCOMES_124_010877
crossref_primary_10_1016_j_hrthm_2019_11_004
crossref_primary_10_1111_jce_15608
crossref_primary_10_1093_europace_euz244
crossref_primary_10_1007_s10554_019_01727_1
crossref_primary_10_1007_s10840_020_00880_1
crossref_primary_10_1111_jce_14193
crossref_primary_10_1002_joa3_12597
crossref_primary_10_1016_j_hrcr_2023_03_016
crossref_primary_10_1111_jce_15041
crossref_primary_10_1111_pace_14751
crossref_primary_10_1007_s00399_018_0586_7
crossref_primary_10_35336_VA_1362
crossref_primary_10_1016_j_hrthm_2024_07_094
crossref_primary_10_2169_naika_107_1744
crossref_primary_10_1093_ehjcr_ytaf101
crossref_primary_10_1093_europace_euad053
crossref_primary_10_1093_europace_euae260
crossref_primary_10_1055_a_1464_0612
crossref_primary_10_3390_jcm12247556
crossref_primary_10_1016_j_ccep_2020_03_001
crossref_primary_10_1093_europace_euaa224
crossref_primary_10_3389_fcvm_2024_1474002
crossref_primary_10_1080_17434440_2020_1768846
crossref_primary_10_1111_pace_14124
crossref_primary_10_1111_pace_14125
crossref_primary_10_1161_CIRCEP_119_007247
crossref_primary_10_1111_pace_14931
crossref_primary_10_1002_joa3_70016
crossref_primary_10_1016_j_jacep_2023_03_020
crossref_primary_10_1007_s12265_020_10037_0
crossref_primary_10_1111_jce_15748
crossref_primary_10_3389_fcvm_2023_1278635
crossref_primary_10_1136_heartjnl_2020_318676
crossref_primary_10_36660_abc_20230544i
crossref_primary_10_1111_jce_15504
crossref_primary_10_1161_CIRCEP_120_009294
crossref_primary_10_1093_europace_euaa354
crossref_primary_10_1080_00015385_2021_1939512
crossref_primary_10_1016_j_hjc_2023_03_001
crossref_primary_10_1111_evj_14037
crossref_primary_10_1093_europace_euab329
crossref_primary_10_1111_jce_16393
crossref_primary_10_1016_j_jacep_2023_06_004
crossref_primary_10_1186_s42444_022_00064_0
crossref_primary_10_1371_journal_pone_0257050
crossref_primary_10_1007_s12325_019_01173_4
crossref_primary_10_1016_j_jacep_2019_05_007
crossref_primary_10_1016_j_hrthm_2020_03_016
crossref_primary_10_1536_ihj_22_091
crossref_primary_10_3390_jcm11030830
crossref_primary_10_1016_j_jacep_2018_08_016
crossref_primary_10_1007_s10840_019_00622_y
crossref_primary_10_1002_joa3_12605
crossref_primary_10_1111_pace_14140
crossref_primary_10_1007_s10840_021_00944_w
crossref_primary_10_1002_joa3_12960
crossref_primary_10_2217_fca_2021_0002
crossref_primary_10_1002_joa3_12601
crossref_primary_10_1155_2022_6009275
crossref_primary_10_3238_PersKardio_2020_04_10_03
crossref_primary_10_1111_jce_14673
crossref_primary_10_1111_jce_14311
crossref_primary_10_1111_jce_15883
crossref_primary_10_35336_VA_1356
crossref_primary_10_1111_jce_14678
crossref_primary_10_1111_jce_14438
crossref_primary_10_3389_fcvm_2023_1276317
crossref_primary_10_3389_fcvm_2023_1332868
crossref_primary_10_1038_s41569_019_0261_7
crossref_primary_10_17925_EJAE_2022_8_1_2
crossref_primary_10_3390_jcdd11040110
crossref_primary_10_3389_fphys_2020_00987
crossref_primary_10_1016_j_hrthm_2020_03_022
Cites_doi 10.1001/jama.2009.2029
10.1093/europace/euv206
10.1016/j.jacc.2014.04.072
10.1093/europace/eus027
10.1111/j.1540-8167.2009.01646.x
10.1093/europace/euw295
10.1111/j.1540-8167.2010.01750.x
10.1056/NEJMoa1602014
10.1111/jce.12303
10.1161/01.CIR.102.1.67
10.1016/j.hrthm.2014.07.033
10.1016/j.hrthm.2016.05.011
10.1161/CIRCEP.115.003041
10.1161/CIRCEP.116.004867
10.1016/j.hrthm.2017.04.024
10.1016/j.hrthm.2015.06.026
10.1161/CIRCULATIONAHA.114.014092
ContentType Journal Article
DBID AAYXX
CITATION
NPM
7X8
ADTOC
UNPAY
DOI 10.1093/europace/eux376
DatabaseName CrossRef
PubMed
MEDLINE - Academic
Unpaywall for CDI: Periodical Content
Unpaywall
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1532-2092
EndPage f427
ExternalDocumentID 10.1093/europace/eux376
29315411
10_1093_europace_eux376
Genre Journal Article
GroupedDBID ---
.2P
.I3
.XZ
.ZR
0R~
29G
2WC
4.4
48X
53G
5GY
5VS
5WA
6PF
70D
AABZA
AACZT
AAJKP
AAJQQ
AAMVS
AAOGV
AAPNW
AAPQZ
AAPXW
AAUAY
AAUQX
AAVAP
AAWTL
AAYXX
ABEJV
ABEUO
ABGNP
ABIXL
ABJNI
ABKDP
ABNHQ
ABNKS
ABPQP
ABPTD
ABQLI
ABVGC
ABWST
ABXVV
ABZBJ
ACGFS
ACPRK
ACUFI
ACUTO
ADBBV
ADEYI
ADEZT
ADGZP
ADHKW
ADHZD
ADOCK
ADRTK
ADVEK
ADYVW
ADZXQ
AEGPL
AEJOX
AEKSI
AEMDU
AEMQT
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFZL
AFIYH
AFOFC
AFXAL
AGINJ
AGKEF
AGQXC
AGSYK
AGUTN
AHMBA
AHXPO
AIJHB
AJEEA
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
AMNDL
APIBT
APWMN
AXUDD
BAWUL
BAYMD
BEYMZ
BHONS
BTRTY
BVRKM
CDBKE
CITATION
CS3
CZ4
DAKXR
DIK
DILTD
DU5
D~K
E3Z
EBD
EBS
EE~
EJD
EMOBN
ENERS
F5P
F9B
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HW0
HZ~
IOX
J21
JXSIZ
KBUDW
KOP
KQ8
KSI
KSN
M-Z
MHKGH
N9A
NGC
NOMLY
NOYVH
O9-
OAUYM
OAWHX
ODMLO
OJQWA
OJZSN
OK1
OPAEJ
OVD
P2P
PAFKI
PEELM
PQQKQ
Q1.
Q5Y
RD5
ROL
RPM
RUSNO
RW1
RXO
SEL
SV3
TCURE
TEORI
TJX
TOX
TR2
VVN
W8F
WOQ
X7H
YAYTL
YKOAZ
YXANX
ZKX
~91
NPM
7X8
--K
1B1
1TH
ADTOC
C1A
CAG
COF
IHE
M41
NQ-
NTWIH
NU-
O0~
RPZ
UHS
UNPAY
ID FETCH-LOGICAL-c404t-5c0409afd46e00c54f3c27bc430f00c30348fbf2f2c1fee0553d170b36b169603
IEDL.DBID UNPAY
ISSN 1099-5129
1532-2092
IngestDate Tue Aug 19 22:04:14 EDT 2025
Thu Oct 02 11:45:33 EDT 2025
Mon Jul 21 05:53:08 EDT 2025
Thu Apr 24 23:01:05 EDT 2025
Tue Jul 01 03:20:18 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue FI_3
Language English
License https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c404t-5c0409afd46e00c54f3c27bc430f00c30348fbf2f2c1fee0553d170b36b169603
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
OpenAccessLink https://proxy.k.utb.cz/login?url=https://academic.oup.com/europace/article-pdf/20/FI_3/f419/26947528/eux376.pdf
PMID 29315411
PQID 1989554299
PQPubID 23479
ParticipantIDs unpaywall_primary_10_1093_europace_eux376
proquest_miscellaneous_1989554299
pubmed_primary_29315411
crossref_citationtrail_10_1093_europace_eux376
crossref_primary_10_1093_europace_eux376
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-11-01
PublicationDateYYYYMMDD 2018-11-01
PublicationDate_xml – month: 11
  year: 2018
  text: 2018-11-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Europace (London, England)
PublicationTitleAlternate Europace
PublicationYear 2018
References Shah ( key 2018120305264948300_eux376-B5) 2010; 21
Taghji ( key 2018120305264948300_eux376-B4) 2017
Ullah ( key 2018120305264948300_eux376-B13) 2016; 13
Afzal ( key 2018120305264948300_eux376-B12) 2015; 12
Calkins ( key 2018120305264948300_eux376-B1) 2012; 14
Reddy ( key 2018120305264948300_eux376-B14) 2015; 132
Kuck ( key 2018120305264948300_eux376-B7) 2016; 374
Andrade ( key 2018120305264948300_eux376-B9) 2014; 11
El Haddad ( key 2018120305264948300_eux376-B3) 2017; 10
Black-Maier ( key 2018120305264948300_eux376-B20) 2017; 14
Kirchhof ( key 2018120305264948300_eux376-B2) 2016; 18
Sarkozy ( key 2018120305264948300_eux376-B6) 2015; 8
Nakagawa ( key 2018120305264948300_eux376-B19) 2013; 10
Halbfass ( key 2018120305264948300_eux376-B21) 2017; 19
Natale ( key 2018120305264948300_eux376-B11) 2014; 64
Itoh ( key 2018120305264948300_eux376-B16) 2016; 18
Reddy ( key 2018120305264948300_eux376-B15) 2016; 2
De Greef ( key 2018120305264948300_eux376-B18) 2010; 21
Wilber ( key 2018120305264948300_eux376-B8) 2010; 303
Marijon ( key 2018120305264948300_eux376-B10) 2014; 25
Tsai ( key 2018120305264948300_eux376-B17) 2000; 102
References_xml – volume: 303
  start-page: 333
  year: 2010
  ident: key 2018120305264948300_eux376-B8
  article-title: Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial
  publication-title: JAMA
  doi: 10.1001/jama.2009.2029
– volume: 18
  start-page: 531
  year: 2016
  ident: key 2018120305264948300_eux376-B16
  article-title: Reduced residual conduction gaps and favourable outcome in contact force-guided circumferential pulmonary vein isolation
  publication-title: Europace
  doi: 10.1093/europace/euv206
– volume: 64
  start-page: 647
  year: 2014
  ident: key 2018120305264948300_eux376-B11
  article-title: Paroxysmal AF catheter ablation with a contact force sensing catheter: results of the prospective, multicenter SMART-AF trial
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2014.04.072
– volume: 14
  start-page: 528
  year: 2012
  ident: key 2018120305264948300_eux376-B1
  article-title: 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design
  publication-title: Europace
  doi: 10.1093/europace/eus027
– volume: 21
  start-page: 381
  year: 2010
  ident: key 2018120305264948300_eux376-B18
  article-title: Triggering pulmonary veins: a paradoxical predictor for atrial fibrillation recurrence after PV isolation
  publication-title: J Cardiovasc Electrophysiol
  doi: 10.1111/j.1540-8167.2009.01646.x
– volume: 18
  start-page: 1609
  year: 2016
  ident: key 2018120305264948300_eux376-B2
  article-title: 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
  publication-title: Europace
  doi: 10.1093/europace/euw295
– volume: 10
  start-page: S481
  year: 2013
  ident: key 2018120305264948300_eux376-B19
  article-title: Prospective study to test the ability to create RF lesions at predicted depths of 3, 5, 7 and 9 mm using a new formula incorporating contact force, radiofrequency power and application time (force-power-time index) in the beating canine heart
  publication-title: Heart Rhythm
– volume: 19
  start-page: 1116
  year: 2017
  ident: key 2018120305264948300_eux376-B21
  article-title: Impact of surround flow catheter tip irrigation in contact force ablation on the incidence of asymptomatic oesophageal lesions after atrial fibrillation ablation: a prospective comparative study
  publication-title: Europace
– volume: 21
  start-page: 1038
  year: 2010
  ident: key 2018120305264948300_eux376-B5
  article-title: Area under the real-time contact force curve (force-time integral) predicts radiofrequency lesion size in an in vitro contractile model
  publication-title: J Cardiovasc Electrophysiol
  doi: 10.1111/j.1540-8167.2010.01750.x
– volume: 2
  start-page: 691
  year: 2016
  ident: key 2018120305264948300_eux376-B15
  article-title: Relationship between catheter stability and 12-month success after pulmonary vein isolation: a subanalysis of the SMART-AF trial
  publication-title: J Am Coll Cardiol
– volume: 374
  start-page: 2235
  year: 2016
  ident: key 2018120305264948300_eux376-B7
  article-title: Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1602014
– volume: 25
  start-page: 130
  year: 2014
  ident: key 2018120305264948300_eux376-B10
  article-title: Real-time contact force sensing for pulmonary vein isolation in the setting of paroxysmal atrial fibrillation: procedural and 1-year results
  publication-title: J Cardiovasc Electrophysiol
  doi: 10.1111/jce.12303
– volume: 102
  start-page: 67
  year: 2000
  ident: key 2018120305264948300_eux376-B17
  article-title: Initiation of atrial fibrillation by ectopic beats originating from the superior vena cava: electrophysiological characteristics and results of radiofrequency ablation
  publication-title: Circulation
  doi: 10.1161/01.CIR.102.1.67
– volume: 11
  start-page: 1919
  year: 2014
  ident: key 2018120305264948300_eux376-B9
  article-title: Pulmonary vein isolation using contact force ablation: the effect on dormant conduction and long-term freedom from recurrent atrial fibrillation. A prospective study
  publication-title: Heart Rhythm
  doi: 10.1016/j.hrthm.2014.07.033
– volume: 13
  start-page: 1761
  year: 2016
  ident: key 2018120305264948300_eux376-B13
  article-title: Randomized trial comparing pulmonary vein isolation using the SmartTouch catheter with or without real-time contact force data
  publication-title: Heart Rhythm
  doi: 10.1016/j.hrthm.2016.05.011
– volume: 8
  start-page: 1342
  year: 2015
  ident: key 2018120305264948300_eux376-B6
  article-title: Contact force in atrial fibrillation: role of atrial rhythm and ventricular contractions: co-force atrial fibrillation study
  publication-title: Circ Arrhythm Electrophysiol
  doi: 10.1161/CIRCEP.115.003041
– volume: 10
  start-page: e004867.
  year: 2017
  ident: key 2018120305264948300_eux376-B3
  article-title: Determinants of acute and late pulmonary vein reconnection in contact force guided pulmonary vein isolation
  publication-title: Circ Arrhythm Electrophysiol
  doi: 10.1161/CIRCEP.116.004867
– year: 2017
  ident: key 2018120305264948300_eux376-B4
  article-title: Evaluation of a strategy aiming to enclose the pulmonary veins with contiguous and optimized radiofrequency lesions in paroxysmal atrial fibrillation: a pilot study
  publication-title: JACC Clinical Electrohysiol
– volume: 14
  start-page: 1328
  year: 2017
  ident: key 2018120305264948300_eux376-B20
  article-title: Risk of atrioesophageal fistula formation with contact force-sensing catheters
  publication-title: Heart Rhythm
  doi: 10.1016/j.hrthm.2017.04.024
– volume: 12
  start-page: 1990
  year: 2015
  ident: key 2018120305264948300_eux376-B12
  article-title: Use of contact force sensing technology during radiofrequency ablation reduces recurrence of atrial fibrillation: a systematic review and meta-analysis
  publication-title: Heart Rhythm
  doi: 10.1016/j.hrthm.2015.06.026
– volume: 132
  start-page: 907
  year: 2015
  ident: key 2018120305264948300_eux376-B14
  article-title: Randomized controlled trial of the safety and effectiveness of a contact-force sensing irrigated catheter for ablation of paroxysmal atrial fibrillation (Toccastar study)
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.114.014092
SSID ssj0007295
Score 2.6336198
Snippet We have recently shown that a contact force (CF)-guided ablation protocol respecting region-specific criteria of lesion contiguity and lesion depth ('CLOSE'...
SourceID unpaywall
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage f419
Title Improving procedural and one-year outcome after contact force-guided pulmonary vein isolation: the role of interlesion distance, ablation index, and contact force variability in the ‘CLOSE’-protocol
URI https://www.ncbi.nlm.nih.gov/pubmed/29315411
https://www.proquest.com/docview/1989554299
https://academic.oup.com/europace/article-pdf/20/FI_3/f419/26947528/eux376.pdf
UnpaywallVersion publishedVersion
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1532-2092
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0007295
  issn: 1099-5129
  databaseCode: KQ8
  dateStart: 19990101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1532-2092
  dateEnd: 20241102
  omitProxy: true
  ssIdentifier: ssj0007295
  issn: 1099-5129
  databaseCode: DIK
  dateStart: 19990101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1532-2092
  dateEnd: 20241102
  omitProxy: true
  ssIdentifier: ssj0007295
  issn: 1099-5129
  databaseCode: GX1
  dateStart: 19990101
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 1532-2092
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0007295
  issn: 1099-5129
  databaseCode: RPM
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVASL
  databaseName: Oxford Journals Open Access Collection
  customDbUrl:
  eissn: 1532-2092
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0007295
  issn: 1099-5129
  databaseCode: TOX
  dateStart: 19990101
  isFulltext: true
  titleUrlDefault: https://academic.oup.com/journals/
  providerName: Oxford University Press
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwEB61W4mfA78Flp_KSBxAqneT2M5uequqrgqiWyS60nKKbMdGK1bJqiSF5dTHgFfiMfokHcfJQkEIIXGMMrYTe8bzJTP-BuCZ4cpGuAniCoSCcs1cNUA9pFzFSloltKwj-Ifj-GDCX03FdA3G7VkY2WSF99ojDY6iAr8eTb-ZSbrILH6x90cvU9a3PEz67izmQERDFP2M5tJDgXXYiAVi8w5sTMZvdt_VIc8koc67eQLVCB8uiVqun4T9GMf3ctlN_YY9r8PVKl_I5Sc5n__kj0Y3oWjfxKehfOhVperpL7-QPP6_V70FNxroSnZ9s9uwZvI7cOWwCc7fhe-rHxSkdouZY_QgMs9IkRu6RJMiRVXiIxhSVyYnLk1e6pIgbtaGvq9mmcnIopqjZciTJTk1s5zM0DZq5dkhCFWJS4YkhSWO5cKlCeANkjkIjLq7TaTysqTmgNyux740CDmVaHB1PvASheouz8--7r0-ert_fvaNOtaKAk1jEyaj_eO9A9qUiqCaB7ykQuNmlEib8dgEgRbcMh0NlOYssHiNfpoPLWqljXRojQmEYFk4CBSLVRijorB70MlxMh4AcXNsFPp2aS32xmUkecY0i3RiOOKpLvRazUh1w6PuynnMUx_PZ2m7jqlfpS48XzVYeAqRP4s-bVUtRTN3sRuZm6L6mLrUNuFqiyVduO91cNUZIjYEwmHYhRcrpfzbSA__QfYRXENLHvoTmI-hU55U5glCsVJtwfrx0XSrsbIL3kk9YQ
linkProvider Unpaywall
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3bbtQwEB2VrcTlgWuB5aZB4gGkejeJ7eyGt6rqqiC6IMFK5SmyHRutWCWrkhSWp34G_BKf0S9hnMtCQQgh8RhlbCf2jOckMz4D8MgK7SLaBGkFQsmE4b4aoBkzoWOtnJZG1RH8g2m8PxPPD-XhBky7szCqzQofdEcaPEUFfT3aYTuTbJk5-mIfTp6lfOhEmAz9WcyRjMYk-onMZUAC52AzloTNe7A5m77aeVuHPJOEee_WEKhG9HBJ1HH9JPzHOE0vZ93Ub9jzElyo8qVafVSLxU_-aHIFiu5NmjSU94Oq1APz-ReSx__3qlfhcgtdcadpdg02bH4dzh-0wfkb8G39gwJrt5h5Rg9UeYZFbtmKTAqLqqRHsFhXJkefJq9MiYSbjWXvqnlmM1xWC7IMdbTCYzvPcU62USvPUySoij4ZEguHnuXCpwnQDcw8BCbd3UalG1msOSC367HPDILHigyuzgdekVDd5enJl90XL1_vnZ58ZZ61oiDT2ILZZO_N7j5rS0UwIwJRMmloM0qUy0Rsg8BI4biJRtoIHji6Jj8txo600kUmdNYGUvIsHAWaxzqMSVH4TejlNBm3Af0cW02-XTlHvQkVKZFxwyOTWEF4qg-DTjNS0_Ko-3Iei7SJ5_O0W8e0WaU-PF43WDYUIn8WfdipWkpm7mM3KrdF9SH1qW3S1xZL-nCr0cF1Z4TYCAiHYR-erJXybyPd-QfZu3CRLHncnMC8B73yqLL3CYqV-kFrX98Bcyo8RQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Improving+procedural+and+one-year+outcome+after+contact+force-guided+pulmonary+vein+isolation%3A+the+role+of+interlesion+distance%2C+ablation+index%2C+and+contact+force+variability+in+the+%27CLOSE%27-protocol&rft.jtitle=Europace+%28London%2C+England%29&rft.au=Phlips%2C+Thomas&rft.au=Taghji%2C+Philippe&rft.au=El+Haddad%2C+Milad&rft.au=Wolf%2C+Michael&rft.date=2018-11-01&rft.eissn=1532-2092&rft.volume=20&rft.issue=FI_3&rft.spage=f419&rft_id=info:doi/10.1093%2Feuropace%2Feux376&rft_id=info%3Apmid%2F29315411&rft.externalDocID=29315411
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1099-5129&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1099-5129&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1099-5129&client=summon